By Daniel R. Matlis The Kaiser Permanente Northern California Division of Research announced yesterday, February 14 2007, that it is launching one of the largest […]
Are you ready for Virtual Clinical Trials? Read More »
By Daniel R. Matlis No, it is not a typo. If you are uninsured, that $4 prescription will probably cost you $1,053. Why so much
That will be 1,053 Dollars for your 4 Dollar prescription Read More »
On February 26, 2004, the FDA published its final rule on “Bar Code Label Requirements for Human Drug Products and Biological Products”. According to the
A Bar-Code In The Hand Is Worth Two RFID Tags In The Bush Read More »
By Daniel R. Matlis In my “Final Word” column, published in Pharmaceutical Formulation and Quality, I discussed the need to deepen our industry’s gene pool.
It’s Time to Deepen the Gene Pool Read More »
This week, Scott Gottlieb, MD Deputy Commissioner for Medical and Scientific Affairs at the Food and Drug Administration made an interesting speech before the 2006
Doctors Don’t Treat Populations, They Treat Individual Patients Read More »
During my senior year, I was lucky to have a few job offers to evaluate. The top two were from Johnson & Johnson and Exxon.
"Medicine is for the People, not for the Profits." Read More »
By Daniel R. Matlis It’s 3:00 AM and your newborn baby wakes up crying. You want to go back to sleep, but his circadian rhythm
I Lost the Cure for the Common Cold! Read More »
By Daniel R. Matlis In his recent InformationWeek article entitled “Let The UBS Trial Be A Warning To You” Mitch Wagner covers the trial against
Are Post-it Notes Security's Worst Enemy? Read More »
